We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy Policy
Vaccines
FDA Approval of Updated Novarax Vaccine
Authorization of an updated Novarax vaccine for individuals aged 12 and older, featuring modifications to include spike protein from the SARS-CoV-2 omicron variant lineage XBB.1.5.
November 2023
Nobel Prize in Physiology and Medicine 2023
Recognition of contributions leading to an unprecedented pace of vaccine development.
October 2023
FDA Evaluation of Updated COVID-19 Vaccines
The FDA evaluates updated monovalent vaccines for COVID-19, specifically for the Pfizer and Moderna mRNA vaccines, considering the prevalence of the most recent variant.
October 2023
COVID-19: Effectiveness of Non-Pharmaceutical Interventions Examined
Effective implementation of non-pharmaceutical interventions buys time to enable the development and manufacturing of drugs and vaccines, highlighting the importance of public health measures in controlling the spread of COVID-19.
October 2023
WHO Warns of ’Worrying Trends’ in COVID-19 Cases
The WHO has raised concerns about increasing COVID-19 cases and urged booster vaccinations to mitigate potential worsening, especially with the onset of cold weather.
October 2023
The US Approves a Vaccine for Pregnant Women Against RSV
Abrysvo, from Pfizer, is approved for use in pregnant women to protect infants during their first six months of life against respiratory syncytial virus (RSV), expanding the available options for maternal immunization.
September 2023
Arexvy Vaccine Receives European Commission Approval for RSV
The Arexvy vaccine, previously approved by the FDA in the US, receives European Commission approval for respiratory syncytial virus (RSV) prevention, with initial doses expected in the fall.
August 2023
Celebrating a Century of BCG Vaccine: Insights into Tuberculosis Prevention
The BCG vaccine’s enduring legacy in tuberculosis prevention underscores its significance in public health, particularly amidst the challenges posed by the COVID-19 pandemic.
June 2023
Promising Results for Chikungunya Fever Vaccine
VLA1553, the first vaccine against chikungunya fever, induces antibody production in 99% of patients, offering hope in the fight against the disease.
June 2023
FDA Approves First RSV Vaccine for Older Adults
New Vaccine Approved for Prevention of Respiratory Syncytial Virus in Older Population.